Expand AMRX Menu
AMRX MENU

AMRX Latest Press Releases

-- June 5, 2026 --

Amneal Announces Full Study Population Interim Phase 4 ELEVATE-PD Results, Reinforcing Previously Reported Benefits of CREXONT in Parkinson's Disease Globe Newswire 8:00 AM

-- June 4, 2026 --

Amneal Announces U.S. FDA Approval of Romidepsin Injection Solution Globe Newswire 8:00 AM

-- June 1, 2026 --

Amneal to Participate in Goldman Sachs 47th Annual Global Healthcare Conference 2026 Globe Newswire 8:00 AM

-- May 7, 2026 --

Amneal Reports First Quarter 2026 Financial Results Globe Newswire 4:01 PM

-- April 22, 2026 --

Kashiv BioSciences Agrees to Be Acquired by Amneal Pharmaceuticals to Create a Fully Integrated Global Biosimilar Leader Business Wire 6:17 AM
Amneal Agrees to Acquire Kashiv BioSciences to Create Global Biosimilar Leader; Reports Strong Preliminary First Quarter 2026 Financial Results and Raises FY2026 Standalone Guidance Globe Newswire 6:00 AM

-- April 20, 2026 --

Amneal Announces Additional Positive Interim Phase 4 ELEVATE-PD Results with CREXONT for Parkinson's Disease, Including Over 3 More Hours of Daily "Good On" Time When Switching from RYTARY Globe Newswire 8:00 AM

-- April 14, 2026 --

Amneal Launches First Two Respiratory Metered-Dose Inhalation Products in the U.S. Globe Newswire 8:00 AM

-- April 9, 2026 --

Amneal Launches Bimatoprost Ophthalmic Solution, 0.01% Globe Newswire 8:00 AM

-- April 7, 2026 --

Amneal to Report First Quarter 2026 Results on May 1, 2026 Globe Newswire 4:01 PM
Amneal Announces $2 Million Donation to Support Patient Access to Essential Medicines During Parkinson's Awareness Month Globe Newswire 8:00 AM

-- March 5, 2026 --

Amneal to Participate in Upcoming Investor Conference Globe Newswire 4:05 PM

-- February 27, 2026 --

Amneal Reports Fourth Quarter and Full Year 2025 Financial Results Globe Newswire 6:00 AM

-- January 28, 2026 --

Amneal Pharmaceuticals Added to S&P SmallCap 600 Index Globe Newswire 4:05 PM

-- January 27, 2026 --

TTM Technologies, Dutch Bros, Advanced Energy Industries, and American Healthcare REIT Set to Join S&P MidCap 400; Others to Join S&P SmallCap 600 PRNewswire 6:03 PM
Amneal to Report Fourth Quarter and Full Year 2025 Results on February 27, 2026 Globe Newswire 8:00 AM

-- January 9, 2026 --

KeifeRx Announces Research Collaboration and Option Agreement with Amneal Pharmaceuticals to Advance KFRX06, a Brain-Penetrant LRRK2 Program for Parkinson's Disease Business Wire 11:00 AM
Market Data Delayed 15 Minutes